16:32 EDT Evolus raises FY24 revenue to $260M-$270M from $255M-$265M, consensus $262.5M
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EOLS:
- Evolus expands global footprint with debut of Nuceiva in Australia
- Evolus (EOLS) Is Capturing the Aesthetic Market with a Flagship Product
- Evolus Announces Board Appointments and Committee Changes
- Evolus appoints Albert White to board of directors
- Evolus announces submission of PMA to U.S. FDA for two Evolysse products